DOAJ Open Access 2021

Alzheimer's disease: Newer biomarkers

Ankit Dangi Kaushik Chatterjee Manjur Shah Banwa Vinay Singh Chauhan Prateek Yadav

Abstrak

Fifty million people are affected with dementia worldwide with Alzheimer's disease (AD) accounting for 70%–80% of these cases. In India alone, 4.1 million people suffered from dementia in 2015. To date, there are no definitive treatment options for AD and the overall treatment gap in India stands at 90%. Attempts have been made to define AD biologically. This has been made possible due to advances in the identification of biomarkers that indicate the neuropathological changes responsible for AD. Identification of these biomarkers has implications for disease staging, prognostication, and identifying drug targets. Here, we summarize the advances in the field of biomarkers in AD.

Topik & Kata Kunci

Psychiatry Industrial psychology

Penulis (5)

Ankit Dangi

Kaushik Chatterjee

Manjur Shah Banwa

Vinay Singh Chauhan

Prateek Yadav

Format Sitasi

APA MLA BibTeX

Dangi, A., Chatterjee, K., Banwa, M.S., Chauhan, V.S., Yadav, P. (2021). Alzheimer's disease: Newer biomarkers. https://doi.org/10.4103/0972-6748.328840

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.4103/0972-6748.328840

Informasi Jurnal

Tahun Terbit: 2021
Sumber Database: DOAJ
DOI: 10.4103/0972-6748.328840
Akses: Open Access ✓